Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Diagnosing Stroke in Acute Dizziness and Vertigo
Stroke 49:788-795, Saber Tehrani, A.S.,et al, 2018
Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Hospitalization in Amyotrophic Lateral Sclerosis, Causes, Costs, and Outcomes
Neurol 56:753-757, Lechtzin,N.,et al, 2001
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
A 45-Year-Old Man with Low Back Pain and a Numb Left Foot
JAMA 280:730-736, Weinstein,J.N., 1998
A 55-Year-Old Man with Attention-Deficit/Hyperactivity Disorder
JAMA 280:1086-1092, Biederman,J., 1998
Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Cost Effectiveness of Oral Compared with IV Antibiotic Therapy for Pts with Early Lyme Dis or Lyme Arthritis
NEJM 337:357-363, Eckman,M.H.,et al, 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Imaging the Brain in Dementia:Expensive and Futile
AJNR 18:1847-1850, George,A.E.,et al, 1997
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Ten Steps in Characterizing and Diagnosing Patients with Peripheral Neuropathy
Neurol 47:10-17, Dyck,P.J.,et al, 1996
Adverse Cerebral Outcomes After Coronary Bypass Surgery
NEJM 335:1857-1863, Roach,G.W.,et al, 1996
A Simplified Six-Item Checklist for Screening for Fragile X Syndrome in the Pediatric Population
J Pediatr 129:611-614, Giangreco,C.A.,et al, 1996
Diagnosis and Evaluation of Dementia
Neurol 45:211-218, Corey-Bloom,J.,et al, 1995
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
The Medical Letter, 36:109-1101994., , 1994
Electroencephalography
JNNP 57:1308-1319, Binnie,C.D.&Prior,P.F., 1994
Brain Single-Photon Emission Computed Tomography
Neurol 44:1970-1977, Masdeu,J.C.,et al, 1994
Home Ventilation for ALS Patients:Outcomes, Costs, and Patient, Family and Physician Attitudes
Neurol 43:438-443, Moss,A.H.,et al, 1993
Time Until Institutionalization and Death in Patients with Dementia
Arch Neurol 50:643-650, Brodaty,H.,et al, 1993